Hoag Layers Compassion Atop Excellence for Leading Urologic Cancer Program

Hoag’s commitment is serving the community. That commitment does not stop short for urologic cancer care, and instead goes above and beyond to ensure access to superior technology and innovative therapies, coupled with physicians and staff who truly care for their patients.

Physicians who treat prostate, bladder, kidney and testicular cancer said Hoag’s focus is a deep commitment to a patient’s quality of life.

It starts with early detection, which ensures that patients are treated appropriately at the earliest stages of disease, when treatments can be less severe, more successful and have fewer side effects. Hoag then pays close attention to every aspect of patient health, creating a comprehensive approach to care that supports the patient and their family at every step.

Jeffrey Yoshida, M.D., fellowship-trained urologic oncologist and program director of Hoag Urologic Oncology and Benjamin and Carmela Du Endowed Chair in Urologic Oncology, said Hoag intentionally developed theprogram to be as comprehensive as possible – taking every aspect of patient care into account. That meant being at the forefront of detection, screening and targeted biopsies to find and treat cancers at the earliest possible stage.

Dr. Yoshida joined Hoag’s Urologic Oncology Program twelve years ago, being the first to bring robotic-assisted prostate surgery to Hoag. “Hoag offers state-of-the-art imaging and surveillance, minimally-invasive surgical options as well as non-surgical options, clinical trials, a multidisciplinary tumor board and extensive support services, generously funded by philanthrophy.”

For individuals with urologic cancer, nurse navigator Sandy Southerland, B.S.N., R.N., O.C.N., is critical to guiding patients through their care journey. The Hoag Pelvic Health Program helps to prevent incontinence and loss of sexual function. And the hospitals’ genetic counselors give generations of patients the knowledge they need to take control of their health.

“These are all things that distinguish us, but what really sets us apart is that we don’t just do the surgery and then send patients on their way. While our surgical volume is very high, and we offer advanced treatment options that make a profound difference in outcomes, we also strive to see our patients succeed and get back to life after their cancer journey,” Dr. Yoshida said.

“Patients want assurance they are placing their care in the best possible hands. At Hoag, we can proudly state we offer the full complement of care, addressing all aspects of a patient’s needs, which I feel makes us unique,” said urologic oncologist Moses Kim, M.D., Ph.D., chair of Urology at Hoag.

Hoag’s introduction of “fusion” prostate biopsy, for example, gave specialists the ability to combine pre-biopsy MRI and ultrasound-guided biopsy imaging to create a 3D image of the prostate. This helps locate suspicious areas, reduce false positives and false negatives and limit the need to remove the entire prostate.

“MRI imaging was a major breakthrough for the diagnosis of prostate cancer. Once we were able to see these areas of the prostate, we added the next layer of targeted biopsy, where we are now able to biopsy these areas more accurately,” Dr. Kim said. “We are finding cancers a lot earlier than we would have otherwise using this groundbreaking technology.”

“By analyzing the biopsy, MRI and PSA information, we can determine whether a prostate cancer is slow growing or aggressive,” continues Dr. Kim. “If a man’s cancer is not going to spread, it is more apt to recommend active surveillance to avoid being over-treated.” Nearly 80% of men who go on an active surveillance protocol will never require treatment. And of the 20% of men whose slow-growing cancer does progress, an active surveillance protocol will catch it in time to successfully treat it.

In addition to detection and surveillance, Hoag offers the most advanced robotic tools and performs the largest number of robotic surgeries than any hospital in the state. Robotic-assisted surgery is often faster, more efficacious and results in fewer complications – including incontinence and sexual dysfunction – than open surgery.

Hoag Hospital Irvine recently became the first hospital in Southern California to offer the da Vinci® single port (SP). Dr. Kim performed the first single port (SP) robotic surgeries in Southern California. “The SP robot allows me to perform complex robotic-assisted surgeries through a single, small incision in the body, leading to less pain, shorter hospital stay, and quicker recovery than before,” said Dr. Kim. “Because of Hoag’s longstanding commitment to investing in cutting edge care, our patients have been among the first to experience the benefits of single-port robotic urologic surgery.”

Hoag is also one of two centers in Southern California that can offer a fully robotic bladder reconstruction surgery. This leads to less stress on the intestines, less stress on the patient and better outcomes.

While advanced treatment is important, cancer is most treatable when caught early. For those concerned about urologic cancer, or any cancer, contact your primary care physician for screening.

For more information, call 888-837-5831.